No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medications.

PubWeight™: 1.06‹?› | Rank: Top 10%

🔗 View Article (PMC 2742564)

Published in Cancer Epidemiol Biomarkers Prev on August 18, 2009

Authors

Thomas P Ahern1, Lars Pedersen, Deirdre P Cronin-Fenton, Henrik Toft Sørensen, Timothy L Lash

Author Affiliations

1: Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, T3E, Boston, MA 02118, USA. tpa@bu.edu

Articles citing this

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ (2010) 4.73

CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark. J Natl Cancer Inst (2011) 1.47

Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncol (2010) 1.07

Using genetics and genomics strategies to personalize therapy for cancer: focus on melanoma. Biochem Pharmacol (2010) 1.06

Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women. Am J Clin Oncol (2013) 1.02

Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes. Expert Rev Clin Pharmacol (2011) 0.91

Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy. Future Oncol (2014) 0.85

CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine. Semin Oncol (2011) 0.83

Risk of emergent bradycardia associated with initiation of immediate- or slow-release metoprolol. Pharmacotherapy (2013) 0.78

Breast cancer recurrence in relation to antidepressant use. Cancer Causes Control (2015) 0.77

Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study. Breast Cancer Res Treat (2016) 0.75

The Impact of CYP2D6 Genotyping on Tamoxifen Treatment. Pharmaceuticals (Basel) (2010) 0.75

Application of Mice Humanized for CYP2D6 to the Study of Tamoxifen Metabolism and Drug-Drug Interaction with Antidepressants. Drug Metab Dispos (2016) 0.75

Articles cited by this

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 42.90

Modeling and variable selection in epidemiologic analysis. Am J Public Health (1989) 15.62

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst (2003) 8.66

Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. Clin Pharmacol Ther (2006) 4.81

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch Pharmacol (2003) 3.34

Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen. Cancer Chemother Pharmacol (2005) 2.41

Empirical-Bayes adjustments for multiple comparisons are sometimes useful. Epidemiology (1991) 2.29

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol (2008) 1.78

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol (1992) 1.71

Genotype-guided tamoxifen therapy: time to pause for reflection? Lancet Oncol (2009) 1.65

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine. Eur J Clin Pharmacol (1996) 1.60

Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes. Biochem Pharmacol (1997) 1.37

The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver. Br J Clin Pharmacol (2002) 1.28

Empirical Bayes adjustments for multiple results in hypothesis-generating or surveillance studies. Cancer Epidemiol Biomarkers Prev (2000) 1.27

Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. Br J Cancer (2008) 1.22

The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand (2004) 1.19

Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting. Eur J Clin Pharmacol (2004) 1.16

Danish Breast Cancer Cooperative Group--DBCG: History, organization, and status of scientific achievements at 30-year anniversary. Acta Oncol (2008) 1.09

Articles by these authors

Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med (2011) 8.62

Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med (2007) 6.30

The Danish National Prescription Registry. Scand J Public Health (2011) 6.07

A method to automate probabilistic sensitivity analyses of misclassified binary variables. Int J Epidemiol (2005) 5.17

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet (2010) 4.90

The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol (2011) 4.54

The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol (2014) 4.30

Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Ann Intern Med (2012) 4.19

Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet (2007) 3.66

Breast cancer treatment of older women in integrated health care settings. J Clin Oncol (2006) 3.46

Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol (2007) 3.42

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology (2006) 3.23

The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol (2009) 3.03

Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol (2010) 2.80

Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol (2009) 2.79

Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology (2010) 2.77

25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ (2012) 2.68

Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf (2010) 2.57

Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg (2007) 2.43

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet (2010) 2.38

A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol (2009) 2.33

Non-melanoma skin cancer and ten-year all-cause mortality: a population-based cohort study. Acta Derm Venereol (2010) 2.28

Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study. BMC Health Serv Res (2008) 2.28

Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst (2011) 2.27

Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med (2003) 2.24

Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res (2009) 2.23

Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol (2002) 2.23

Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med (2006) 2.16

Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study. Am J Epidemiol (2011) 2.12

Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol (2007) 2.11

Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol (2010) 2.10

Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J (2013) 2.00

Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study. Blood (2011) 1.97

Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol (2007) 1.95

Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer (2007) 1.94

Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med (2013) 1.91

Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology (2006) 1.87

Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology (2011) 1.86

Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol (2003) 1.85

Seasonal variation in hospital discharge diagnosis of atrial fibrillation: a population-based study. Epidemiology (2002) 1.85

Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther (2002) 1.82

Acute stress reaction and completed suicide. Int J Epidemiol (2010) 1.82

Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods. Med Care (2012) 1.82

Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions. Clin Epidemiol (2012) 1.77

Older patients with acute stroke in Denmark: quality of care and short-term mortality. A nationwide follow-up study. Age Ageing (2007) 1.77

Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol (2002) 1.75

Predictive value of stroke and transient ischemic attack discharge diagnoses in The Danish National Registry of Patients. J Clin Epidemiol (2002) 1.74

Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study. Cancer (2012) 1.74

Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol (2013) 1.71

Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut (2011) 1.70

The impact of comorbidity on cancer survival: a review. Clin Epidemiol (2013) 1.68

Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol (2010) 1.66

Genotype-guided tamoxifen therapy: time to pause for reflection? Lancet Oncol (2009) 1.65

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ (2011) 1.65

Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med (2007) 1.65

2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry). J Am Coll Cardiol (2009) 1.65

An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod (2009) 1.64

Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open (2011) 1.64

Cohort profile: the Danish Web-based Pregnancy Planning Study--'Snart-Gravid'. Int J Epidemiol (2008) 1.62

Crohn's disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol (2010) 1.61

Prevalence of hypospadias in Danish boys: a longitudinal study, 1977-2005. Eur Urol (2009) 1.60

Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study. Am J Gastroenterol (2003) 1.60

Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial). Am J Cardiol (2012) 1.59

What's wrong with the National Ambient Air Quality Standard (NAAQS) for fine particulate matter (PM(2.5))? Regul Toxicol Pharmacol (2002) 1.59

A prospective cohort study of physical activity and time to pregnancy. Fertil Steril (2012) 1.58

Parity and risk of subarachnoid hemorrhage in women: a nested case-control study based on national Swedish registries. Stroke (2003) 1.58

A successful implementation of e-epidemiology: the Danish pregnancy planning study 'Snart-Gravid'. Eur J Epidemiol (2010) 1.57

A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat (2006) 1.57

Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev (2010) 1.55

Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease. EuroIntervention (2012) 1.55

β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomarkers Prev (2011) 1.55

Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ (2008) 1.54

Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol (2010) 1.51

Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina. Cancer (2005) 1.50

Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction. Circ Cardiovasc Interv (2008) 1.49

Maternal smoking and risk of hypertrophic infantile pyloric stenosis: 10 year population based cohort study. BMJ (2002) 1.48

Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax (2012) 1.48

CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark. J Natl Cancer Inst (2011) 1.47